Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
A hedge fund made a sizable new bet on Centuri Holdings, disclosed in an SEC filing. This article breaks down the num...
As housing markets shift in 2026, Dave Ramsey’s year-long luxury rent strategy is back in focus. This analysis explai...
Berkshire Hathaway agrees to acquire Taylor Morrison for $72.50 per share in cash, valuing the company at roughly $6....
The Trade Desk surprised with strong earnings, yet its stock fell. This in-depth analysis breaks down the reasons beh...
Si-Bone stock soared almost 20% on Tuesday as investors reacted to strong quarterly results and optimistic guidance. ...
A notable stake increase from Fortress Private Ledger in the First Eagle Global Equity ETF signals confidence in glob...
Investors often chase Berkshire Hathaway's stock picks, but the real driver of lasting success is the company’s opera...
A fresh AMD collaboration sparked a sharp move in Rackspace shares. This article breaks down what happened, why it ma...
Imagine starting 2026 with $10,000 in intel. By mid-2026, that stake could push past $30,000 as the stock rallied. Th...
On Feb 18, KVUE defied expectations with a stronger quarter, lifting the stock even as the market edged higher. Here’...
A blockbuster deal reshapes the media landscape and leaves Netflix with a substantial windfall. This article breaks d...